Back to JAZZ

Rhenman & Partners Asset Management AB → JAZZ

Rhenman & Partners Asset Management AB JAZZ Position History

Jazz Pharmaceuticals plc • Healthcare

Quarters held
4
Latest value
$15.7M
Q3 2026
Peak value
$21.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$12.6M
Q1 2026$14.3M
Q2 2026$21.1M
Q3 2026$15.7M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.7M67.8K——
Q2 2026$21.1M87.4K——
Q1 2026$14.3M75.9K——
Q4 2025$12.6M74.0K——

Other funds holding JAZZ

Other Rhenman & Partners Asset Management AB positions

REGN

REGENERON PHARMACEUTICALS

$47.4M
LLY

LILLY ELI & CO

$45.4M
BSX

BOSTON SCIENTIFIC CORP

$41.1M
BSX

BOSTON SCIENTIFIC CORP

$39.2M
UNH

UNITED HEALTH GROUP INC

$38.9M
REGN

REGENERON PHARMACEUTICALS

$37.2M
JPM-PM

IOVANCE BIOTHERAPEUTICS INC

$37.1M
LLY

LILLY ELI & CO

$31M